[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352839-105":59,"doc-detail-352839-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bridging-the-lung-cancer-screening-eligibility-gap-evaluation-of-guideline-applicability-in-asymptomatic-patients","Bridging the lung cancer screening eligibility gap - evaluation of guideline applicability in asymptomatic patients","","Early-onset (\u003C50 years) and never-smoker lung cancers are increasing globally, challenging screening guidance that targets adults >50 years with heavy smoking histories. In China, a nationwide multicenter hospital-based observational study evaluated US Preventive Services Task Force (USPSTF) 2021 eligibility criteria and tested whether real-world data could improve their applicability. Among 106,266 asymptomatic resected primary lung cancer patients, only 8.8% met USPSTF 2021 criteria.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bridging-the-lung-cancer-screening-eligibility-gap-evaluation-of-guideline-applicability-in-asymptomatic-patients/352839/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bridging-the-lung-cancer-screening-eligibility-gap-evaluation-of-guideline-applicability-in-asymptomatic-patients/352839.png","ImageObject",300,407,{"name":92,"@type":93},"Melati","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which eligibility criteria were evaluated for lung cancer screening in the study?","Question",{"text":112,"@type":113},"The study used the US Preventive Services Task Force (USPSTF) 2021 screening criteria as the primary definition of high-risk individuals eligible for lung cancer screening.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many asymptomatic patients met USPSTF 2021 eligibility criteria?",{"text":117,"@type":113},"Among 102,555 patients with complete age and smoking information, 8.8% (8985/102,555) met the USPSTF 2021 eligibility criteria.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study conclude about the USPSTF criteria for China?",{"text":121,"@type":113},"Rigid age- and smoking-based criteria overlooked substantial at-risk populations in China, and individualized risk stratification was considered essential to advance equitable screening.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352839,1790178497,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962085570644,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Wang et al. Mil Med Res 2026  \n[https://doi.org/10.1016/j.mmr.2026.100020](https://doi.org/10.1016/j.mmr.2026.100020)  \nRESEARCH Open Access  \nBridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients  \nChen-Ran Wang1,2†, Ren-Da Li3†, Pan Wang3†, Xue-Si Dong1,2†, Hao Zhang3, Qing-Peng Zeng3, Jia-Xin Xie1,2, Zi-Lin Luo1,2, Xiao-Lu Chen1,2, Ya-Di Zheng1,2, Ji-Bin Li1,2, Yong-Jie Xu1,2, Fei Wang1,2, Ni Li1,2*, Feng-Wei Tan3* and Jie He3*  \nAbstract  \nBackground: Early-onset (\u003C50 years) and never-smoker lung cancers are increasing global concerns. The emerging trends challenge current screening guidelines, which focus on adults aged >50 years with heavy smoking histories. We applied the US Preventive Services Task Force (USPSTF) 2021 screening criteria as the primary definition of high-risk individuals eligible for lung cancer screening and assessed the potential optimization of these criteria using real-world lung cancer data in China.  \nMethods: In this nationwide, multicenter, hospital-based observational study, we enrolled asymptomatic patients with surgically resected primary lung cancer across 26 tertiary hospitals from January 1, 2014 to December 31, 2021. Screening eligibility was classified using USPSTF 2021 criteria (aged 50–80 years, ≥20 pack-year smoking history, and ≤15 quit-years for former smokers) . Temporal trends in eligibility, screening utilization, and mortality risks were assessed through joinpoint regression and Cox proportional hazards models.  \nResults: A total of 106,266 asymptomatic patients with lung cancer were enrolled. Among the 102,555 patients with complete age and smoking information, only 8.8%(8985/102,555) met the USPSTF 2021 eligibility criteria. The eligibility proportion declined sharply from 21.6%(350/1617) in 2014 to 6.1%(1737/28,582) in 2021, with the annual percentage change being –17.4%[95% confidence interval (CI)–19.1 to –15.9] . Patients with screening utilization, irrespective of eligibility status, demonstrated a higher proportion of stage Ia diagnoses compared with those who were not screened. Screening- ineligible group exhibited 40% lower mortality risk overall [adjusted hazard ratio (HR)=0.60, 95% CI 0.55–0.66], with consistent survival advantages across stage I (adjusted HR=0.63, 95% CI 0.54–0.74) and stage Ⅲ (adjusted HR=0.76, 95% CI 0.64–0.90) subgroups.  \nConclusions: Rigid age-and smoking-based criteria overlook substantial at-risk populations in China. Implementing individualized risk stratification is essential to advance equitable lung cancer screening.  \nClinical trial registration: NCT06255197  \nKey words Lung cancer, Screening eligibility, US Preventive Services Task Force (VSPSTF) criteria, Real-world evidence  \nBackground  \nLung cancer accounted for 12.4% of all newly diagnosed cancer cases and 18.7% of all cancer-related deaths worldwide in 2022 [ 1]. In China, lung cancer is the top cancer type of cancerassociated incidence and mortality, representing 22.0% of new  \n†Chen-Ran Wang, Ren-Da Li, Pan Wang, and Xue-Si Dong contributed equally to this work  \n*Correspondence: Ni Li, [nli@cicams.ac.cn](nli@cicams.ac.cn); Feng-Wei Tan, tanfengwei@cicams. [ac.cn](ac.cn); Jie He, [hejie@cicams.ac.cn](hejie@cicams.ac.cn)  \n1Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China  \n3Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China  \nFull list of author information is available at the end of the article  \ncancer cases and 28.5% of total cancer deaths, respectively [2]. While traditionally considered a disease of heavy smokers aged ≥50 years, emerging epidemiological patterns reveal a concerning rise in early-onset case","cbCaicyYpQxtkvVZ","https://ap.wps.com/l/cbCaicyYpQxtkvVZ","pdf",2210729,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Additional Information\n## Clinical trial registration\n## Key words","[{\"question\":\"Which eligibility criteria were evaluated for lung cancer screening in the study?\",\"answer\":\"The study used the US Preventive Services Task Force (USPSTF) 2021 screening criteria as the primary definition of high-risk individuals eligible for lung cancer screening.\"},{\"question\":\"How many asymptomatic patients met USPSTF 2021 eligibility criteria?\",\"answer\":\"Among 102,555 patients with complete age and smoking information, 8.8% (8985/102,555) met the USPSTF 2021 eligibility criteria.\"},{\"question\":\"What did the study conclude about the USPSTF criteria for China?\",\"answer\":\"Rigid age- and smoking-based criteria overlooked substantial at-risk populations in China, and individualized risk stratification was considered essential to advance equitable screening.\"}]","Bridging the lung cancer screening eligibility gap - evaluation of guideline applicability in asymptomatic patients | PDF",1790101664,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec0a7f526974576809d61229f9d76310.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d670ccb61358864449bf292a4c981d90.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/294ac6666d427bdfab781a7c28e88e7e.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/90b7cb53abe6435538103b32ba13d8f0.webp",980,1306]